{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:14:34Z","timestamp":1778832874504,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008360","name":"Hamilton Health Sciences","doi-asserted-by":"publisher","award":["19482"],"award-info":[{"award-number":["19482"]}],"id":[{"id":"10.13039\/100008360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008360","name":"Hamilton Health Sciences","doi-asserted-by":"publisher","award":["NIF-19482"],"award-info":[{"award-number":["NIF-19482"]}],"id":[{"id":"10.13039\/100008360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jgo.2024.101735","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T09:59:46Z","timestamp":1709891986000},"page":"101735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A structured oral chemotherapy teaching tool to improve adherence in adults with multiple myeloma: A pilot randomized controlled trial"],"prefix":"10.1016","volume":"15","author":[{"given":"Imran","family":"Haider","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory R.","family":"Pond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruthanne","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Aljama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom C.","family":"Kouroukis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirk","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Fiala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya M.","family":"Wildes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hira","family":"Mian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2024.101735_bb0005","author":"National Cancer Institute Surveillance E, and End Results Program (Cancer Stat Facts: Myeloma)"},{"issue":"11","key":"10.1016\/j.jgo.2024.101735_bb0010","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jgo.2024.101735_bb0015","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S1470-2045(13)70380-2","article-title":"Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial","volume":"14","author":"Miguel","year":"2013","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.jgo.2024.101735_bb0020","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJMoa1402551","article-title":"Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma","volume":"371","author":"Benboubker","year":"2014","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jgo.2024.101735_bb0025","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S1470-2045(21)00466-6","article-title":"Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial","volume":"22","author":"Facon","year":"2021","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.jgo.2024.101735_bb0030","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.jgo.2024.101735_bb0035","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1547-5069.2003.tb00001.x","article-title":"Adherence to long-term therapies: evidence for action","volume":"35","author":"Burkhart","year":"2003","journal-title":"J Nurs Scholarsh"},{"issue":"10","key":"10.1016\/j.jgo.2024.101735_bb0040","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.clml.2022.05.003","article-title":"Real world adherence to and persistence with oral oncolytics in multiple myeloma: a systematic review and meta-analysis","volume":"22","author":"Naser","year":"2022","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jgo.2024.101735_bb0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ctrv.2017.05.002","article-title":"Adherence to oral cancer therapy in older adults: the International Society of Geriatric Oncology (SIOG) taskforce recommendations","volume":"57","author":"Mislang","year":"2017","journal-title":"Cancer Treat Rev"},{"issue":"14","key":"10.1016\/j.jgo.2024.101735_bb0050","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1200\/JCO.2009.26.3087","article-title":"Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib","volume":"28","author":"Marin","year":"2010","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jgo.2024.101735_bb0055","first-page":"215","article-title":"Costs and utilization associated with imatinib adherence in patients with chronic myeloid leukemia or gastrointestinal stromal turmors","volume":"16","author":"Halpern","year":"2009","journal-title":"J Clin Outcomes Manag"},{"issue":"1","key":"10.1016\/j.jgo.2024.101735_bb0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1185\/03007990903396469","article-title":"Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients","volume":"26","author":"Wu","year":"2010","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"10.1016\/j.jgo.2024.101735_bb0065","first-page":"583","article-title":"Development of the MASCC teaching tool for patients receiving oral agents for cancer","volume":"18","author":"Kav","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jgo.2024.101735_bb0070","author":"Rittenberg"},{"issue":"4","key":"10.1016\/j.jgo.2024.101735_bb0075","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1188\/15.ONF.383-389","article-title":"A structured nursing intervention to address oral chemotherapy adherence in patients with non-small cell lung cancer","volume":"42","author":"Boucher","year":"2015","journal-title":"Oncol Nurs Forum"},{"issue":"4","key":"10.1016\/j.jgo.2024.101735_bb0080","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4103\/apjon.apjon_35_17","article-title":"The effect of structured education to patients receiving oral agents for cancer treatment on medication adherence and self-efficacy","volume":"4","author":"Tokdemir","year":"2017","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"5","key":"10.1016\/j.jgo.2024.101735_bb0085","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1200\/JOP.2016.019729","article-title":"Treatment satisfaction and adherence to oral chemotherapy in patients with cancer","volume":"13","author":"Jacobs","year":"2017","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.jgo.2024.101735_bb0090","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2147\/PPA.S165749","article-title":"Self-efficacy for medication management: a systematic review of instruments","volume":"12","author":"Lamarche","year":"2018","journal-title":"Patient Prefer Adherence"},{"issue":"6","key":"10.1016\/j.jgo.2024.101735_bb0095","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the eastern cooperative oncology group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jgo.2024.101735_bb0100","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood.2019000758","article-title":"Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies","volume":"134","author":"Liu","year":"2019","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.jgo.2024.101735_bb0105","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","article-title":"Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an international myeloma working group report","volume":"125","author":"Palumbo","year":"2015","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.jgo.2024.101735_bb0110","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1200\/JCO.2018.78.8687","article-title":"Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology","volume":"36","author":"Mohile","year":"2018","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jgo.2024.101735_bb0115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1200\/JOP.2017.026435","article-title":"What every oncologist should know about geriatric assessment for older patients with cancer: Young International Society of Geriatric Oncology Position Paper","volume":"14","author":"Loh","year":"2018","journal-title":"J Oncol Pract"},{"issue":"3","key":"10.1016\/j.jgo.2024.101735_bb0120","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10880-014-9407-2","article-title":"The patient-doctor relationship questionnaire (PDRQ-9) in primary care: a validity study","volume":"21","author":"Porcerelli","year":"2014","journal-title":"J Clin Psychol Med Settings"},{"issue":"1","key":"10.1016\/j.jgo.2024.101735_bb0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11136-015-1062-z","article-title":"Reliability and validity of the cancer therapy satisfaction questionnaire in lung cancer","volume":"25","author":"Cheung","year":"2016","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.jgo.2024.101735_bb0130","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1524-4733.2007.00310.x","article-title":"Psychometric validation of the cancer therapy satisfaction questionnaire","volume":"11","author":"Trask","year":"2008","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.jgo.2024.101735_bb0135","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s11136-017-1527-3","article-title":"Validation of the PROMIS((R)) measures of self-efficacy for managing chronic conditions","volume":"26","author":"Gruber-Baldini","year":"2017","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.jgo.2024.101735_bb0140","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/bcp.12942","article-title":"A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence","volume":"82","author":"El Alili","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.jgo.2024.101735_bb0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.6004\/jnccn.2018.7098","article-title":"Patient experiences with oral chemotherapy: adherence, symptoms, and quality of life","volume":"17","author":"Jacobs","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"10.1016\/j.jgo.2024.101735_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214446","article-title":"Adherence to immunomodulatory drugs in patients with multiple myeloma","volume":"14","author":"Cransac","year":"2019","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.jgo.2024.101735_bb0155","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.clml.2019.09.618","article-title":"Adherence to Lenalidomide in older adults with newly diagnosed multiple myeloma","volume":"20","author":"Mian","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"10.1016\/j.jgo.2024.101735_bb0160","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/1078155221993528","article-title":"Adherence to thalidomide in patients with multiple myeloma: a cross-sectional study in a Brazilian metropolis","volume":"28","author":"Silveira","year":"2022","journal-title":"J Oncol Pharm Pract"},{"issue":"1\u20133","key":"10.1016\/j.jgo.2024.101735_bb0165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.schres.2007.12.470","article-title":"The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder","volume":"100","author":"Byerly","year":"2008","journal-title":"Schizophr Res"},{"issue":"4","key":"10.1016\/j.jgo.2024.101735_bb0170","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s13142-015-0315-2","article-title":"Self-report measures of medication adherence behavior: recommendations on optimal use","volume":"5","author":"Stirratt","year":"2015","journal-title":"Transl Behav Med"},{"issue":"7","key":"10.1016\/j.jgo.2024.101735_bb0175","article-title":"A pilot study of adherence to lenalidomide among older patients with multiple myeloma","volume":"14","author":"Silberstein","year":"2023","journal-title":"J Geriatric Oncol"},{"issue":"5","key":"10.1016\/j.jgo.2024.101735_bb0180","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/intqhc\/8.5.447","article-title":"The relationship between meeting patients\u2019 information needs and their satisfaction with hospital care and general health status outcomes","volume":"8","author":"Larson","year":"1996","journal-title":"International J Qual Health Care"},{"issue":"4","key":"10.1016\/j.jgo.2024.101735_bb0185","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ejcnurse.2006.01.004","article-title":"The relationship between in-hospital information and patient satisfaction after acute myocardial infarction","volume":"5","author":"Oterhals","year":"2006","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"2","key":"10.1016\/j.jgo.2024.101735_bb0190","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/ajhp\/zxz284","article-title":"A systematic overview of systematic reviews evaluating medication adherence interventions","volume":"77","author":"Anderson","year":"2020","journal-title":"Am J Health-Syst Pharm"},{"issue":"15","key":"10.1016\/j.jgo.2024.101735_bb0195","article-title":"Factors associated with non-adherence to lenalidomide in patients with multiple myeloma","volume":"36","author":"Leng","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2024.101735_bb0200","doi-asserted-by":"crossref","unstructured":"Loh KP, Soto-Perez-de-Celis E, Hsu T, et al. What every oncologist should know about geriatric assessment for older patients with Cancer: Young International Society of Geriatric Oncology Position Paper. J Oncol Pract 2018;14(2):85\u201394. (In eng). DOI: https:\/\/doi.org\/10.1200\/jop.2017.026435.","DOI":"10.1200\/JOP.2017.026435"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187940682400033X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187940682400033X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:02:40Z","timestamp":1778832160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187940682400033X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S187940682400033X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2024.101735","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A structured oral chemotherapy teaching tool to improve adherence in adults with multiple myeloma: A pilot randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2024.101735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101735"}}